Rankings
▼
Calendar
ELAN Q3 2023 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena
ELAN
Elanco Animal Health Incorporated
$12B
Q3 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.1B
+4.1% YoY
Gross Profit
$441M
41.3% margin
Operating Income
$42M
3.9% margin
Net Income
-$1.1B
-102.6% margin
EPS (Diluted)
$-2.22
QoQ Revenue Growth
+1.0%
Cash Flow
Operating Cash Flow
$198M
Free Cash Flow
$165M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$14.3B
Total Liabilities
$8.2B
Stockholders' Equity
$6.1B
Cash & Equivalents
$369M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.1B
$1.0B
+4.1%
Gross Profit
$441M
$426M
+3.5%
Operating Income
$42M
$50M
-16.0%
Net Income
-$1.1B
-$65M
-1586.2%
Revenue Segments
Farm Animal
$561M
35%
Pet Health
$495M
31%
Cattle
$242M
15%
Poultry
$184M
12%
Swine
$93M
6%
Contract Manufacturing
$12M
1%
Geographic Segments
Non-US
$589M
55%
UNITED STATES
$479M
45%
← FY 2023
All Quarters
Q4 2023 →